Cure Rare Disease Inc

Analysis

Cure Rare Disease Inc is a registered charity in United States, based in Woodbridge, CT. It received its IRS tax-exemption ruling in April 2018, 8 years ago. Its declared purposes cover diseases, disorders and medical disciplines, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending July 2023, Cure Rare Disease Inc reported income of $2.3m and spending of $2.0m, spending 85% of its income. Across the 5 years on record, from July 2019 to July 2023, income grew from $348k to $2.3m (+561%), an average of +60% a year. The sharpest change came in the year to July 2021, when income rose by 174%. Over the whole period it spent 89% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Cure Rare Disease Inc sits at the 73rd percentile: it is larger than about 73% of them. Against every charity in United States with reported income it ranks in the 87th percentile, and in the 85th percentile within CT. Charities of a similar size with the same main cause include Dignity Health Foundation-Inland Empire ($2.3m), Addiction Policy Forum ($2.3m) and Retina Research Foundation ($2.3m).

On its Form 990 for the period ending July 2023, revenue came from contributions and grants 88% of the total. Compensation of current officers, directors and key employees was $95k (4.9% of expenses). Other salaries and wages came to $11k. At year end it held assets of $3.3m against liabilities of $2.3m, net assets of $1.0m. It reported 5 employees.